The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Dylan-hyde Tyler since year 2005.
The trader's CIK number is 1682027.
At the time of this reporting, Dylan-hyde Tyler is the Chief Legal Officer of Crispr Therapeutics Ag .
(stock ticker symbol CRSP).
See this page for all insider trading activities at Crispr Therapeutics Ag .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-08-04||CRSP||Crispr Therapeutics Ag||Sale||477||18.55||8,848|
|2017-08-07||CRSP||Crispr Therapeutics Ag||Sale||13,210||18.56||245,204|
|2017-08-08||CRSP||Crispr Therapeutics Ag||Sale||1,313||18.60||24,421|
|2017-05-01||CRSP||Crispr Therapeutics Ag||Sale||1,852||16.61||30,754|
|2017-04-26||CRSP||Crispr Therapeutics Ag||Sale||3,200||16.76||53,641|
|2017-04-27||CRSP||Crispr Therapeutics Ag||Sale||13,527||16.84||227,794|
|2017-04-28||CRSP||Crispr Therapeutics Ag||Sale||4,912||16.62||81,637|
|2017-04-21||CRSP||Crispr Therapeutics Ag||Sale||3,010||17.02||51,221|
|2017-04-24||CRSP||Crispr Therapeutics Ag||Sale||3,522||16.44||57,898|
|2017-04-25||CRSP||Crispr Therapeutics Ag||Sale||4,800||16.87||80,990|
|2017-04-19||CRSP||Crispr Therapeutics Ag||Sale||7,240||18.04||130,587|
|2017-04-20||CRSP||Crispr Therapeutics Ag||Sale||2,937||17.37||51,024|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dylan-hyde Tyler (Chief Legal Officer of Crispr Therapeutics Ag at the time of this reporting) see the Securities and Exchange Commission (SEC) website.